Market Size

The global proteomics market, valued at USD 35.7 billion in 2025, is projected to reach USD 40.2 billion in 2026 and USD 94.7 billion by 2035, with a 10.0% CAGR during the forecast period 2026 to 2035.

Global Proteomics Market Growth 2026 to 2035

See What’s in the Full Report–Request Your Complimentary Insights!

Market Report: Key Takeaways

Market Size & Trends

In terms of type of offering, the kits and reagents segment holds the highest share (75%) of the market.
With regards to type of instrument / technology, the spectrometry segment dominates the global market with close to 30% market share.
Based on the type of kit and reagent, the spectrometry reagents hold the largest market share (nearly 90%) in 2026.
In terms of types of proteomics service, the core proteomics services dominate the global market with more than 60% market share.
With respect to application area, diagnostics segment captures the highest share in 2026.
With regards to end users, the pharmaceutical and biotechnology companies segment dominates the global market.
In terms of geographical regions, North America captures the majority of the market share, and Asia-Pacific is likely to grow at a faster pace in the near future.

Key Market Statistics

Market Size in 2026: $40.2 Billion
Estimated Market Size in 2035: $94.7 Billion
CAGR (2026-2035): 10.0%
North America: Largest market in 2026
Asia-Pacific: Fastest growing region

Market Overview

Since the discovery of the first human genetic map in 1987, the field of omics-based analysis has evolved significantly. Omics-based analysis is primarily aimed at identifying, describing, and quantifying large sets of biological molecules within a cell. Although, the number of omics technologies is ever expanding, the most advanced omics technologies include genomics, proteomics, transcriptomics and metabolomics. Interestingly, the success of genomics, marked by the completion of the Human Genome Project has paved the way for advancements in other omics disciplines, such as proteomics. Scientists have increasingly focused their efforts on proteomics to address several crucial challenges in understanding diseases at a molecular level. Proteomics is the large-scale analysis of proteins in a cell, tissue or organism, to understand their structure, function, and interactions. It offers deeper insights into the dynamic processes within cells and tissues by analyzing the entire set of proteins (also known as proteome) expressed by the cell.

Proteomics employs advanced technologies, such as mass spectrometry, crystallography, protein microarrays, and bioinformatics to analyze and quantify proteins, providing a holistic view of the cellular functions. This comprehensive approach has led to the identification of novel biomarkers for early disease diagnosis, development of targeted drug candidates, and a holistic understanding of drug resistance mechanisms.

Proteomics has the ability to unravel the complexities of biological processes and the intricate mechanisms of diseases such as Alzheimer’s disease, cancer, and multiple sclerosis. Owing to this, it has significantly revolutionized the landscape of biomedical research and healthcare by addressing several crucial challenges in understanding various diseases at a molecular level.

In order to capitalize the growing opportunity within this rapidly evolving market, the proteomics solution providers are engaged in improving the penetration of their proprietary technologies, within the diverse client-base, including biopharma companies, academic research centers and research institutes. For this purpose, pharmaceutical companies are striving to integrate advanced high-throughput technologies (such as next generation mass spectrometers) and multi-omics approaches in their proteomics workflow. These technologies coupled with the improved computational tools have contributed to the enhanced sensitivity, accuracy, and pace of protein analysis.

Researchers are leveraging emerging technologies, namely single-cell proteomics, spatial proteomics, and advanced imaging techniques, to decode the complex cellular heterogeneity and disease mechanisms. Moreover, the advent of artificial intelligence and machine learning algorithms is transforming data analysis, enabling predictive modeling, and accelerating the discovery of novel biomarkers. Owing to this, the adoption of these novel proteomics solutions to scale research from discovery to translational and clinical phases, is on the rise.

Driven by the growing adoption of proteomics solutions and continuous innovation in this domain, we are led to believe that the opportunity for proteomics market is likely to witness sustained market growth over the forecast period.

Get an Instant Quote in 10 Minutes. Lowest Price Guaranteed

Recent Developments

In February 2026, Illumina announced a customer breakthrough in oncology using Illumina’s spatial transcriptomics, proteomics, and epigenomics. The ability to combine more than one omic insight reveals biological depth, all of which is streamlined by Illumina Connected Multiomics for multimodal data analysis.
In February 2026, Nautilus Biotechnology launched the Voyager™ Platform, which is designed to power the Iterative Mapping of up to 10 billion intact proteins and proteoforms simultaneously in a single run.
In January 2026, Illumina announced the acquisition of SomaLogic to fuel growth in the booming proteomics market, by improving customer access to proteomics solutions and multiomics capabilities.
In October 2025, Thermo Fischer Scientific entered into a strategic collaboration with AstraZeneca BioventureHub for conducting R&D in the field of proteomic, molecular genomics and chromatography.

Market Trends

Technological Advancements: The proteomics market growth is primarily driven by the ongoing technological advancements in mass spectrometers (for instance introduction of 4D proteomics) and bioinformatics (such as improved computational tools driven by AI and machine learning). These advancements are optimizing the proteomics process, thereby fueling the adoption of proteomics solutions in the pharmaceutical industry. In addition, increasing demand for personalized and precision therapies have emerged as the key drivers for the growing adoption of such solutions in the overall pharma market. In this context, over 10 novel personalized therapeutic modalities are anticipated to be approved by the US FDA, each year, till 2026.
Growing Demand for Personalized Medicine: Presently, therapy developers are constantly looking out for opportunities to utilize the solutions offered by the proteomics providers, in order to streamline their development process and cater to the rising demand for personalized therapies. Further, substantial funding from governments and private organizations for proteomics infrastructure development and research is also boosting the market growth.

Market Share by Type of Offering

Kits and reagents segment occupies the highest share currently and is expected to remain dominant during the forecast period.
This can be attributed to the fact that kits and reagents are required to be replenished frequently, thus generating a recurring stream of revenue for the companies.

Market Share by Type of Proteomics Services

Given the fundamental role of core proteomics (which includes protein identification, quantification and characterization) in research and clinical diagnostics applications, coupled with need for high-cost specialized equipment, core proteomics services segment is anticipated to capture the highest share and is expected to remain dominant during the forecast period.

Proteomics Market by Proteomics Services Type 2026 to 2035

Market Share by Type of Instrument / Technology

The global proteomics market is segmented across various types of instruments / technologies, including chromatography, electrophoresis, protein microarrays, novel spectrometry, surface plasmon resonance, X-ray crystallography, and other technologies, based on types of instruments / technologies.
Given that spectrometry is considered as the “gold standard” for protein analysis in proteomics industry, this segment holds the largest market share.
Further, the increasing use of novel protein microarrays, particularly in studying molecular interactions is expected to drive the growth of the overall proteomics industry.

Want Information on Specific Region / Segment?

Market Share by Type of Kit and Reagent

Spectrometry reagents segment occupy the highest share in the overall market and is expected to remain dominant during the forecast period. This can be attributed to the fact that spectrometry is a well-established technique, owing to its unparalleled sensitivity, specificity and versatility.
Owing to this, kits and reagents used in spectrometry, are likely to dominate the market.
In addition, low manufacturing expenses for reagents lead to its lower costs, enabling competitive pricing and accessibility for a wider customer base. Consequently, these reagents are witnessing high demand, driving substantial revenues in the overall proteomics market.

Market Share by Application Area

Research segment will have highest proteomics market share due to the significant role of proteomics in understanding biological processes, identifying drug targets, discovering biomarkers, and developing new therapies, the market share for research application is likely to grow at a higher CAGR in the coming years as compared to the diagnostics and other applications segment in the proteomics industry.

Market Share by End User

Pharmaceutical and biotechnology companies capture the highest share and this segment is expected to dominate the market during the forecast period.
This can be attributed to the recent increase in the interest of big pharma players in evaluating several proteomics platforms that can be seamlessly integrated into their process workflows for more accurate biomarker identification, in order to advance their preclinical and clinical drug candidates.

Market Share by Geography

According to our proteomics market forecast, North America captures the majority proteomics market share (>40%), and this trend is unlikely to change during the forecast period.
This can be attributed to the technical advancements and capability expansions related to proteomics in the developed countries, such as the US.
It is worth highlighting that the market for proteomics in Asia-Pacific is expected to grow at a relatively higher CAGR (11.7%), during the forecast period.
Detailed methodology across the global proteomics industry and revenue generated across various segments is available in the full report.

Pay Only for What You Need – The Best Way to Optimize

Market Insights

Competitive Landscape of Proteomics Solution Providers

The current market landscape seems to be well-fragmented, featuring the presence of both new entrants and established players. Stakeholders in this domain offer various types of instruments, technologies, kits and reagents, proteomics services, across different application areas including clinical diagnostics and research. Majority of the proteomics solution providers offer mass spectrometry solutions, owing to their wide use in the analysis of biological samples.

Interestingly, in order to capitalize the growing opportunity within this flourishing market, the proteomics companies have undertaken several initiatives, such as entering into strategic collaborations, and expanding their existing capabilities / product portfolios.

Global Proteomics Market Size Analysis: Spectrometry to Drive Market Growth

The global market opportunity for proteomics solution providers is estimated to be worth USD 40.2 billion currently. In terms of type of instrument / technology, the market for spectrometry is anticipated to capture the largest market share, during the forecast period. The proteomics market growth is primarily driven by its broad applicability in research applications, facilitated by analytical instruments that offer enhanced sensitivity, improved resolution and high throughput output data.

Leading Proteomics Solution Providers in the Industry

Examples of key proteomics solution providers involved in the proteomics industry (which have also been captured in this market report, arranged in alphabetical order) include Agilent Technologies, Allele Life Sciences, Bertis, BGI Genomics, Bio-Rad Laboratories, Bruker, CellCarta, Creative Biolabs, Creative Proteomics, Cytiva, Macrogen, Merck, Nautilus, Olink, PerkinElmer, Promega, Promise Proteomic, Proteome Factory, Proteome Sciences, Proteomics International, SCIEX, Seer, SomaLogic, Thermo Fisher Scientific and VProteomics. This market report includes an easily searchable excel database for all the companies offering proteomics-related products / services for various industrial, research and therapeutic applications.

Have Questions? Let’s Get Them Answered.

Market Segmentation Insights

Key Report Attributes

Key Report Attributes	Details
Historical Trend	Since 2020
Forecast Period	2026-2035
Future Trend	Till 2035
Market Size, 2026	40.2 billion
Market Size, 2035	94.7 billion
CAGR (Till 2035)	10.0%
Type of Offering	Instruments Kits and Reagents Proteomics Services
Type of Instrument / Technology	Chromatography (Affinity, High -performance Liquid Chromatography, Ion and Supercritical Fluid) Electrophoresis (Capillary and Gel Electrophoresis) Protein Microarray (Macroarrays and Microchips) Spectrometry (Circular Dichroism, Mass Spectroscopy and Nuclear Magnetic Resonance) Surface Plasmon Resonance X-ray Crystallography Other Technologies
Type of Kit and Reagent	Chromatography Reagents Electrophoresis Reagents Immunoassay Reagents Protein Microarray Reagents Spectroscopy Reagents, X-ray Crystallography Reagents Other Reagents
Type of Proteomics Service	Bioinformatics Services Core Proteomics Services
Application Area	Diagnostics Research (Drug Discovery, and Basic and Translational Research) Other Applications
End User	Academic and Research Institutes Clinical Laboratories and Hospitals Pharmaceutical and Biotechnology Companies Other End users
Geography	North America (US, Canada and Rest of North America) Europe (France, Germany, Italy, Spain, UK and Rest of Europe) Asia-Pacific (India, China, Japan, South Korea and Rest of Asia-Pacific) Latin America (Brazil and Rest of Latin America) Middle East and North Africa (Israel and Rest of Middle East and North Africa) Rest of the World (South Africa and Rest of the World)
Key Players	Agilent Allele Life Sciences Bertis BGI Genomics Bio-Rad Laboratories Bruker Corporation CellCarta Creative Biolabs Creative proteomics Cytiva Macrogen Merck Nautilus Olink PerkinElmer Promega Promise Proteomics Proteome Factory Proteome Sciences Proteomics International SCIEX Seer SomaLogic Thermo Fisher Scientific VProteomics (Full list of 100+ companies captured is available in the report)
Customization Scope	15% Free Customization
Excel Data Packs	Market Landscape Company Competitiveness Analysis Market Forecast and Opportunity Analysis

+ 1. RESEARCH METHODOLOGY

1.1. Chapter Overview

1.2. Research Assumptions

1.3. Project Methodology

1.4. Forecast Methodology

1.5. Robust Quality Control

1.6. Key Market Segmentations

1.7. Key Considerations

1.7.1. Demographics

1.7.2. Economic Factors

1.7.3. Government Regulations

1.7.4. Supply Chain

1.7.5. COVID Impact

1.7.6. Market Access

1.7.7. Healthcare Policies

1.7.8. Industry Consolidation

+ 2. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

2.1. Chapter Overview

2.2. Market Dynamics

2.2.1. Time Period

2.2.1.1. Historical Trends

2.2.1.2. Current and Forecasted Estimates

2.2.2. Currency Coverage and Foreign Exchange Rate

2.2.2.1. Major Currencies Affecting the Market

2.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rates

2.2.2.3. Impact of Foreign Exchange Rate Volatility on the Market

2.2.2.4. Strategies For Mitigating Foreign Exchange Risk

2.2.3. Trade Policies

2.2.3.1. Impact of Trade Barriers on the Market

2.2.3.2. Strategies for Mitigating the Risks Associated with Trade Barriers

2.2.4. Recession

2.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt

2.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

2.2.5. Inflation

2.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy

2.2.5.2. Potential Impact of Inflation on the Market Evolution

+ 3. EXECUTIVE SUMMARY

+ 4. INTRODUCTION

4.1. An Overview of Proteomics

4.2. Steps involved in Proteomics Process

4.3. Types of Proteomics

4.4. Applications of Proteomics

4.5. Challenges in Proteomics Domain

4.6. Recent Trends in Proteomics Domain

+ 5. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

5.1. Market Drivers

5.2. Market Restraints

5.3. Market Opportunities

5.4. Market Challenges

+ 6. GLOBAL PROTEOMICS MARKET

6.1. Key Assumptions and Methodology

6.2. Global Proteomics Market, till 2035

6.2.1. Scenario Analysis

6.2.1.1. Conservative Scenario

6.2.1.2. Optimistic Scenario

+ 7. PROTEOMICS MARKET, BY TYPE OF OFFERING

7.1. Key Assumptions and Methodology

7.2. Proteomics Market: Distribution by Type of Offering, 2020, 2024 and 2035

7.2.1. Proteomics Market for Instruments / Technologies, till 2035

7.2.2. Proteomics Market for Kits and Reagents, till 2035

7.2.3. Proteomics Market for Proteomics Services, till 2035

8. PROTEOMICS MARKET, BY TYPE OF INSTRUMENT / TECHNOLOGY

8.1. Key Assumptions and Methodology

8.2. Proteomics Market: Distribution by Type of Instrument / Technology, 2020, 2024 and 2035

8.2.1. Proteomics Market for Chromatography, till 2035

8.2.1.1. Proteomics Market for Affinity Chromatography, till 2035

8.2.1.2. Proteomics Market for High Performance Liquid Chromatography, till 2035

8.2.1.3. Proteomics Market for Ion Chromatography, till 2035

8.2.1.4. Proteomics Market for Supercritical Fluid Chromatography, till 2035

8.2.2. Proteomics Market for Electrophoresis, till 2035

8.2.2.1. Proteomics Market for Proteomics Market for Capillary Electrophoresis, till 2035

8.2.2.2. Proteomics Market for Proteomics Market for Gel Electrophoresis, till 2035

8.2.3. Proteomics Market for Protein Microarrays, till 2035

8.2.3.1. Proteomics Market for Microarrays, till 2035

8.2.3.2. Proteomics Market for Microchips, till 2035

8.2.4. Proteomics Market for Spectrometry, till 2035

8.2.4.1. Proteomics Market for Circular Dichroism, till 2035

8.2.4.2. Proteomics Market for Mass Spectroscopy, till 2035

8.2.4.3. Proteomics Market for Nuclear Magnetic Resonance, till 2035

8.2.5. Proteomics Market for Surface Plasmon Resonance, till 2035

8.2.6. Proteomics Market for X-ray Crystallography, till 2035

8.2.7. Proteomics Market for Other Technologies, till 2035

+ 9. PROTEOMICS MARKET, BY TYPE OF KIT AND REAGENT

9.1. Key Assumptions and Methodology

9.2. Proteomics Market: Distribution by Type of Kit and Reagent, 2020, 2024 and 2035

9.2.1. Proteomics Market for Chromatography Reagents, till 2035

9.2.2. Proteomics Market for Electrophoresis Reagents, till 2035

9.2.3. Proteomics Market for Immunoassay Reagents, till 2035

9.2.4. Proteomics Market for Protein Microarray Reagents, till 2035

9.2.5. Proteomics Market for X-ray Crystallography Reagents, till 2035

9.2.6. Proteomics Market for Other Reagents, till 2035

+ 10. PROTEOMICS MARKET, BY TYPE OF PROTEOMICS SERVICE

10.1. Key Assumptions and Methodology

10.2. Proteomics Market: Distribution by Type of Proteomics Service, 2020, 2024 and 2035

10.2.1. Proteomics Market for Bioinformatics Services, till 2035

10.2.2. Proteomics Market for Core Proteomics Services, till 2035

+ 11. PROTEOMICS MARKET, BY APPLICATION AREA

11.1. Key Assumptions and Methodology

11.2. Proteomics Market: Distribution by Application Area, 2020, 2024 and 2035

11.2.1. Proteomics Market for Diagnostics, till 2035

11.2.2. Proteomics Market for Research: Till 2035

11.2.2.1. Proteomics Market for Basic and Translational Research, till 2035

11.2.2.2. Proteomics Market for Drug Discovery, till 2035

11.2.3. Proteomics Market for Other Applications, till 2035

+ 12. PROTEOMICS MARKET, BY END USER

12.1. Key Assumptions and Methodology

12.2. Proteomics Market: Distribution by Type of End User, 2020, 2024 and 2035

12.2.1. Proteomics Market for Academic and Research Institutes, till 2035

12.2.2. Proteomics Market for Clinical Laboratories and Hospitals, till 2035

12.2.3. Proteomics Market for Pharmaceutical / Biotechnology Companies, till 2035

12.2.4. Proteomics Market for Other End Users, till 2035

+ 13. PROTEOMICS MARKET, BY GEOGRAPHY

13.1. Key Assumptions and Methodology

13.2. Proteomics Market: Distribution by Geography, 2020, 2024 and 2035

13.2.1. Proteomics Market in North America, till 2035

13.2.1.1. Proteomics Market in the US, till2035

13.2.1.2. Proteomics Market in Canada, till2035

13.2.1.3. Proteomics Market in Rest of North America, till2035

13.2.2. Proteomics Market in Europe, till2035

13.2.2.1. Proteomics Market in Germany, till2035

13.2.2.2. Proteomics Market in France, till2035

13.2.2.3. Proteomics Market in the UK, till 2035

13.2.2.4. Proteomics Market in Italy, till 2035

13.2.2.5. Proteomics Market in Spain, till 2035

13.2.2.6. Proteomics Market in Rest of Europe, till 2035

13.2.3. Proteomics Market in Asia-Pacific, till 2035

13.2.3.1. Proteomics Market in South Korea, till 2035

13.2.3.2. Proteomics Market in China, till 2035

13.2.3.3. Proteomics Market in Japan, till 2035

13.2.3.4. Proteomics Market in India, till 2035

13.2.3.5. Proteomics Market in Rest of Asia-Pacific, till 2035

13.2.4. Proteomics Market in Latin America, till 2035

13.2.4.1. Proteomics Market in Brazil, till 2035

13.2.4.2. Proteomics Market in Rest of Latin America, till 2035

13.2.5. Proteomics Market in Middle East and North Africa, till 2035

13.2.5.1. Proteomics Market in Israel, till 2035

13.2.5.2. Proteomics Market in Rest of Middle East and North Africa, till 2035

13.2.6. Proteomics Market in Rest of the World, till 2035

13.2.6.1. Proteomics Market in South Africa, till 2035

13.2.6.2. Proteomics Market in Other Countries, till 2035

+ 14. MARKET LANDSCAPE: KEY PROTEOMICS SOLUTION PROVIDERS

14.1. Key Proteomics Solution Providers: Overall Market Landscape

14.1.1. Analysis by Year of Establishment

14.1.2. Analysis by Company Size

14.1.3. Analysis by Location of Headquarters (Region)

14.1.4. Analysis by Location of Headquarters (Country)

14.1.5. Analysis by Type of Offering

14.1.6. Analysis by Type of Instrument / Technology Involved

14.1.7. Analysis by Type of Solution Offered

14.1.8. Analysis by Application Area

+ 15. COMPANY COMPETITIVENESS ANALYSIS: KEY PROTEOMICS SOLUTION PROVIDERS

15.1. Key Parameters and Methodology

15.2. Company Competitiveness Analysis: Key Proteomics Solution Providers

15.3. Benchmarking Analysis of Key Proteomics Solution Providers

15.3.1. Spider Web Analysis: Benchmarking of Key Players

15.3.2. Parameter-wise Benchmarking of Proteomics Solution Providers

15.3.2.1. By Years of Experience

15.3.2.2. By Company Size

15.3.2.3. By Application Area

15.3.2.4. By Number of Offerings

15.3.2.5. By Number of Instruments / Technologies

15.3.2.6. By Number of Solutions Offered

+ 16. COMPANY PROFILES: PROTEOMICS SOLUTION PROVIDERS HEADQUARTERED IN NORTH AMERICA

16.1. Agilent Technologies

16.1.1. Company Details

16.1.2. Proteomics-related Offerings

16.1.3. Financial Details

16.1.4. Recent Developments and Future Outlook

16.2. Bruker

16.3. Creative Biolabs

16.4. Nautilus Biotechnology

16.5. PerkinElmer

16.6. Seer

16.7. Thermo Fisher Scientific

16.8. Bio - Rad Laboratories

16.9. CellCarta

16.10. Creative Proteomics

16.11. Cytiva

16.12. Promega

16.13. SCIEX

16.14. SomaLogic

16.15. Key Winning Strategies

+ 17. COMPANY PROFILES: PROTEOMICS SOLUTION PROVIDERS HEADQUARTERED IN EUROPE

17.1. Merck

17.1.1. Company Details

17.1.2. Proteomics-related Offerings

17.1.3. Financial Details

17.1.4. Recent Developments and Future Outlook

17.2. Olink

17.3. Promise Proteomics

17.4. Proteome Factory

17.5. Proteome Sciences

17.6. Key Winning Strategies

+ 18. COMPANY PROFILES: PROTEOMICS SOLUTION PROVIDERS HEADQUARTERED IN ASIA-PACIFIC

18.1. Proteomics International

18.1.1. Company Details

18.1.2. Proteomics-related Offerings

18.1.3. Financial Details

18.1.4. Recent Developments and Future Outlook

18.2. Macrogen

18.3. Allele Life Sciences

18.4. Bertis

18.5. BGI Genomics

18.6. VProteomics

18.7. Key Winning Strategies

+ 19. PROTEOMICS MARKET: MEGATRENDS ANALYSIS

19.1. Megatrends in the Proteomics Market

19.1.1. Advancements of Novel Mass Spectrometers

19.1.2. Development of Bioinformatics Tools and Big Data

19.1.3. Label-free Quantification Techniques

19.1.4. Adoption of Artificial Intelligence and Machine Leaning

19.1.5. Integration of Multi-omics

19.1.6. Emergence of Single Cell Proteomics and Proteogenomics

19.1.7. Applications in Precision Medicine

19.1.8. Evolving Regulatory Guidelines

+ 20. VALUE CHAIN ANALYSIS

+ 21. EXECUTIVE INSIGHTS

+ 22. APPENDIX 1: TABULATED DATA

+ 23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

+ List of Figures

Figure 1.1 Research Methodology: Research Assumptions

Figure 1.2 Research Methodology: Project Methodology

Figure 1.3 Research Methodology: Forecast Methodology

Figure 1.4 Research Methodology: Robust Quality Control

Figure 1.5 Research Methodology: Key Market Segmentations

Figure 3.1 Executive Summary: Market Sizing and Opportunity Analysis

Figure 3.2 Executive Summary: Market Landscape of Key Proteomics Solution Providers

Figure 4.1 Steps involved in Proteomics Process

Figure 6.1 Global Proteomics Market, till 2035 (USD Billion)

Figure 6.2 Global Proteomics Market, till 2035: Conservative Scenario (USD Billion)

Figure 6.3 Global Proteomics Market, till 2035: Optimistic Scenario (USD Billion)

Figure 6.4 Global Proteomics Market: Distribution by Type of Offering, 2020, 2024 and 2035 (USD Million)

Figure 7.1 Proteomics Market for Instruments / Technologies, till 2035 (USD Million)

Figure 7.2 Proteomics Market for Kits and Reagents, till 2035 (USD Million)

Figure 7.3 Proteomics Market for Proteomics Services, till 2035 (USD Million)

Figure 8.1 Global Proteomics Market: Distribution by Type of Instrument / Technology, 2020, 2024 and 2035 (USD Million)

Figure 8.2 Proteomics Market for Chromatography, till 2035 (USD Million)

Figure 8.3 Proteomics Market for Affinity Chromatography, till 2035 (USD Million)

Figure 8.4 Proteomics Market for High Performance Liquid Chromatography, till 2035 (USD Million)

Figure 8.5 Proteomics Market for Ion Chromatography, till 2035 (USD Million)

Figure 8.6 Proteomics Market for Supercritical Fluid Chromatography, till 2035 (USD Million)

Figure 8.7 Proteomics Market for Electrophoresis, till 2035 (USD Million)

Figure 8.8 Proteomics Market for Capillary Electrophoresis, till 2035 (USD Million)

Figure 8.9 Proteomics Market for Gel Electrophoresis, till 2035 (USD Million)

Figure 8.10 Proteomics Market for Protein Microarrays, till 2035 (USD Million)

Figure 8.11 Proteomics Market for Microarrays, till 2035 (USD Million)

Figure 8.12 Proteomics Market for Microchips, till 2035 (USD Million)

Figure 8.13 Proteomics Market for Spectrometry, till 2035 (USD Million)

Figure 8.14 Proteomics Market for Circular Dichroism, till 2035 (USD Million)

Figure 8.15 Proteomics Market for Mass Spectroscopy, till 2035 (USD Million)

Figure 8.16 Proteomics Market for Nuclear Magnetic Resonance, till 2035 (USD Million)

Figure 8.17 Proteomics Market for Surface Plasmon Resonance, till 2035 (USD Million)

Figure 8.18 Proteomics Market for X-ray Crystallography, till 2035 (USD Million)

Figure 8.19 Proteomics Market for Other Technologies, till 2035 (USD Million)

Figure 9.1 Global Proteomics Market: Distribution by Type of Kit and Reagent, 2020, 2024 and 2035 (USD Million)

Figure 9.2 Proteomics Market for Chromatography Reagents, till 2035 (USD Million)

Figure 9.3 Proteomics Market for Electrophoresis Reagents, till 2035 (USD Million)

Figure 9.4 Proteomics Market for Immunoassay Reagents, till 2035 (USD Million)

Figure 9.5 Proteomics Market for Protein Microarray Reagents, till 2035 (USD Million)

Figure 9.6 Proteomics Market for X-ray Crystallography Reagents, till 2035 (USD Million)

Figure 9.7 Proteomics Market for Other Reagents, till 2035 (USD Million)

Figure 10.1 Global Proteomics Market: Distribution by Type of Proteomics Service, 2020, 2024 and 2035 (USD Million)

Figure 10.2 Proteomics Market for Bioinformatics Services, till 2035 (USD Million)

Figure 10.3 Proteomics Market for Core Proteomics Services, till 2035 (USD Million)

Figure 11.1 Global Proteomics Market: Distribution by Application Area, 2020, 2024 and 2035 (USD Million)

Figure 11.2 Proteomics Market for Diagnostics, till 2035 (USD Million)

Figure 11.3 Proteomics Market for Research, till 2035 (USD Million)

Figure 11.4 Proteomics Market for Basic and Translational Research, till 2035 (USD Million)

Figure 11.5 Proteomics Market for Drug Discovery, till 2035 (USD Million)

Figure 11.6 Proteomics Market for Other Applications, till 2035 (USD Million)

Figure 12.1 Global Proteomics Market: Distribution by End User, 2020, 2024 and 2035 (USD Million)

Figure 12.2 Proteomics Market for Academic and Research Institutes, till 2035 (USD Million)

Figure 12.3 Proteomics Market for Clinical Laboratories and Hospitals, till 2035 (USD Million)

Figure 12.4 Proteomics Market for Pharmaceutical / Biotechnology Companies, till 2035 (USD Million)

Figure 12.5 Proteomics Market for Other End Users, till 2035 (USD Million)

Figure 13.1 Global Proteomics Market: Distribution by Geography, 2020, 2024 and 2035 (USD Million)

Figure 13.2 Proteomics Market in North America, till 2035 (USD Million)

Figure 13.3 Proteomics Market in the US, till 2035 (USD Million)

Figure 13.4 Proteomics Market in Canada, till 2035 (USD Million)

Figure 13.5 Proteomics Market in Rest of North America, till 2035 (USD Million)

Figure 13.6 Proteomics Market in Europe, till 2035 (USD Million)

Figure 13.7 Proteomics Market in Germany, till 2035 (USD Million)

Figure 13.8 Proteomics Market in France, till 2035 (USD Million)

Figure 13.9 Proteomics Market in the UK, till 2035 (USD Million)

Figure 13.10 Proteomics Market in Italy, till 2035 (USD Million)

Figure 13.11 Proteomics Market in Spain, till 2035 (USD Million)

Figure 13.12 Proteomics Market in Rest of Europe, till 2035 (USD Million)

Figure 13.13 Proteomics Market in Asia-Pacific, till 2035 (USD Million)

Figure 13.14 Proteomics Market in South Korea, till 2035 (USD Million)

Figure 13.15 Proteomics Market in China, till 2035 (USD Million)

Figure 13.16 Proteomics Market in Japan, till 2035 (USD Million)

Figure 13.17 Proteomics Market in India, till 2035 (USD Million)

Figure 13.18 Proteomics Market in Rest of Asia-Pacific, till 2035 (USD Million)

Figure 13.19 Proteomics Market in Latin America, till 2035 (USD Million)

Figure 13.20 Proteomics Market in Brazil, till 2035 (USD Million)

Figure 13.21 Proteomics Market in Rest of Latin America, till 2035 (USD Million)

Figure 13.22 Proteomics Market in Middle East and North Africa, till 2035 (USD Million)

Figure 13.23 Proteomics Market in Israel, till 2035 (USD Million)

Figure 13.24 Proteomics Market in Rest of Middle East and North Africa, till 2035 (USD Million)

Figure 13.25 Proteomics Market in Rest of the World, till 2035 (USD Million)

Figure 13.26 Proteomics Market in South Africa, till 2035 (USD Million)

Figure 13.27 Proteomics Market in Other Countries, till 2035 (USD Million)

Figure 14.1 Key Proteomics Solution Providers: Distribution by Year of Establishment

Figure 14.2 Key Proteomics Solution Providers: Distribution by Company Size

Figure 14.3 Key Proteomics Solution Providers: Distribution by Location of Headquarters (Region)

Figure 14.4 Key Proteomics Solution Providers: Distribution by Location of Headquarters (Country)

Figure 14.5 Key Proteomics: Distribution by Type of Offering

Figure 14.6 Key Proteomics: Distribution by Type of Instrument / Technology

Figure 14.7 Key Proteomics: Distribution by Type of Solution Offered

Figure 14.8 Key Proteomics: Distribution by Application Area

Figure 15.1 Key Proteomics Solution Providers: 3-D Bubble Chart

Figure 15.2 Spider Web Analysis: Agilent Technologies

Figure 15.3 Spider Web Analysis: Bruker

Figure 15.4 Spider Web Analysis: CellCarta

Figure 15.5 Spider Web Analysis: Creative Biolabs

Figure 15.6 Spider Web Analysis: Creative Proteomics

Figure 15.7 Spider Web Analysis: Olink

Figure 15.8 Spider Web Analysis: SCIEX

Figure 15.9 Spider Web Analysis: SomaLogic

Figure 15.10 Spider Web Analysis: Bertis

Figure 15.11 Spider Web Analysis: Bio - Rad Laboratories

Figure 15.12 Parameter-wise Benchmarking: By Years of Experience

Figure 15.13 Parameter-wise Benchmarking: By Company Size

Figure 15.14 Parameter-wise Benchmarking: By Application Area

Figure 15.15 Parameter-wise Benchmarking: By Number of Offerings

Figure 15.16 Parameter-wise Benchmarking: By Number of Instruments / Technologies

Figure 15.17 Parameter-wise Benchmarking: By Number of Solutions Offered

Figure 16.1 Agilent Technologies: Annual Revenues, FY 2021-FY 2023 (USD Billion)

Figure 16.2 Bio - Rad Laboratories: Annual Revenues, FY 2021-FY 2023 (USD Billion)

Figure 16.3 Bruker: Annual Revenues, FY 2021-FY 2023 (USD Billion)

Figure 16.4 PerkinElmer: Annual Revenues, FY 2021-FY 2023 (USD Billion)

Figure 16.5 Seer: Annual Revenues, FY 2021-FY 2023 (USD Million)

Figure 16.6 Thermo Fisher Scientific: Annual Revenues, FY 2021-FY 2023 (USD Billion)

Figure 17.1 Merck: Annual Revenues, FY 2021-FY 2023 (EUR Billion)

Figure 17.2 Olink: Annual Revenues, FY 2021-FY 2023 (USD Million)

Figure 18.1 Proteomics International: Annual Revenues, FY 2021-FY 2023 (USD Million)

+ List of Tables

Table 14.1 List of Key Proteomics Solution Providers

Table 14.2 Key Proteomics Solution Providers: Information on Type of Offering and Type of Instrument / Technology Involved

Table 14.3 Key Proteomics Solution Providers: Information on Type of Solution Offered and Application Area

Table 22.1 Global Proteomics Market, till 2035 (USD Billion)

Table 22.2 Global Proteomics Market, till 2035: Conservative Scenario (USD Billion)

Table 22.3 Global Proteomics Market, till 2035: Optimistic Scenario (USD Billion)

Table 22.4 Global Proteomics Market: Distribution by Type of Offering, 2020, 2024 and 2035 (USD Million)

Table 22.5 Proteomics Market for Instruments / Technologies, till 2035 (USD Million)

Table 22.6 Proteomics Market for Kits and Reagents, till 2035 (USD Million)

Table 22.7 Proteomics Market for Proteomics Services, till 2035 (USD Million)

Table 22.8 Global Proteomics Market: Distribution by Type of Instrument / Technology, 2020, 2024 and 2035 (USD Million)

Table 22.9 Proteomics Market for Chromatography, till 2035 (USD Million)

Table 22.10 Proteomics Market for Affinity Chromatography, till 2035 (USD Million)

Table 22.11 Proteomics Market for High Performance Liquid Chromatography, till 2035 (USD Million)

Table 22.12 Proteomics Market for Ion Chromatography, till 2035 (USD Million)

Table 22.13 Proteomics Market for Supercritical Fluid Chromatography, till 2035 (USD Million)

Table 22.14 Proteomics Market for Electrophoresis, till 2035 (USD Million)

Table 22.15 Proteomics Market for Capillary Electrophoresis, till 2035 (USD Million)

Table 22.16 Proteomics Market for Gel Electrophoresis, till 2035 (USD Million)

Table 22.17 Proteomics Market for Protein Microarrays, till 2035 (USD Million)

Table 22.18 Proteomics Market for Microarrays, till 2035 (USD Million)

Table 22.19 Proteomics Market for Microchips, till 2035 (USD Million)

Table 22.20 Proteomics Market for Spectrometry, till 2035 (USD Million)

Table 22.21 Proteomics Market for Circular Dichroism, till 2035 (USD Million)

Table 22.22 Proteomics Market for Mass Spectroscopy, till 2035 (USD Million)

Table 22.23 Proteomics Market for Nuclear Magnetic Resonance, till 2035 (USD Million)

Table 22.24 Proteomics Market for Surface Plasmon Resonance, till 2035 (USD Million)

Table 22.25 Proteomics Market for X-ray Crystallography, till 2035 (USD Million)

Table 22.26 Proteomics Market for Other Technologies, till 2035 (USD Million)

Table 22.27 Global Proteomics Market: Distribution by Type of Kit and Reagent, 2020, 2024 and 2035 (USD Million)

Table 22.28 Proteomics Market for Chromatography Reagents, till 2035 (USD Million)

Table 22.29 Proteomics Market for Electrophoresis Reagents, till 2035 (USD Million)

Table 22.30 Proteomics Market for Immunoassay Reagents, till 2035 (USD Million)

Table 22.31 Proteomics Market for Protein Microarray Reagents, till 2035 (USD Million)

Table 22.32 Proteomics Market for X-ray Crystallography Reagents, till 2035 (USD Million)

Table 22.33 Proteomics Market for Other Reagents, till 2035(USD Million)

Table 22.34 Global Proteomics Market: Distribution by Type of Proteomics Service, 2020, 2024 and 2035 (USD Million)

Table 22.35 Proteomics Market for Bioinformatics Services, till 2035 (USD Million)

Table 22.36 Proteomics Market for Core Proteomics Services, till 2035 (USD Million)

Table 22.37 Global Proteomics Market: Distribution by Application Area, 2020, 2024 and 2035 (USD Million)

Table 22.38 Proteomics Market for Diagnostics, till 2035 (USD Million)

Table 22.39 Proteomics Market for Research, till 2035 (USD Million)

Table 22.40 Proteomics Market for Basic and Translational Research, till 2035 (USD Million)

Table 22.41 Proteomics Market for Drug Discovery, till 2035 (USD Million)

Table 22.42 Proteomics Market for Other Applications, till 2035 (USD Million)

Table 22.43 Global Proteomics Market: Distribution by End User, 2020, 2024 and 2035 (USD Million)

Table 22.44 Proteomics Market for Academic and Research Institutes, till 2035 (USD Million)

Table 22.45 Proteomics Market for Clinical Laboratories and Hospitals, till 2035 (USD Million)

Table 22.46 Proteomics Market for Pharmaceutical / Biotechnology Companies, till 2035 (USD Million)

Table 22.47 Proteomics Market for Other End Users, till 2035 (USD Million)

Table 22.48 Global Proteomics Market: Distribution by Geography, 2020, 2024 and 2035 (USD Million)

Table 22.49 Proteomics Market in North America, till 2035 (USD Million)

Table 22.50 Proteomics Market in the US, till 2035 (USD Million)

Table 22.51 Proteomics Market in Canada, till 2035 (USD Million)

Table 22.52 Proteomics Market in Rest of North America, till 2035 (USD Million)

Table 22.53 Proteomics Market in Europe, till 2035 (USD Million)

Table 22.54 Proteomics Market in Germany, till 2035 (USD Million)

Table 22.55 Proteomics Market in France, till 2035 (USD Million)

Table 22.56 Proteomics Market in the UK, till 2035 (USD Million)

Table 22.57 Proteomics Market in Italy, till 2035 (USD Million)

Table 22.58 Proteomics Market in Spain, till 2035 (USD Million)

Table 22.59 Proteomics Market in Rest of Europe, till 2035 (USD Million)

Table 22.60 Proteomics Market in Asia-Pacific, till 2035 (USD Million)

Table 22.61 Proteomics Market in South Korea, till 2035 (USD Million)

Table 22.62 Proteomics Market in China, till 2035 (USD Million)

Table 22.63 Proteomics Market in Japan, till 2035 (USD Million)

Table 22.64 Proteomics Market in India, till 2035 (USD Million)

Table 22.65 Proteomics Market in Rest of Asia-Pacific, till 2035 (USD Million)

Table 22.66 Proteomics Market in Latin America, till 2035 (USD Million)

Table 22.67 Proteomics Market in Brazil, till 2035 (USD Million)

Table 22.68 Proteomics Market in Rest of Latin America, till 2035 (USD Million)

Table 22.69 Proteomics Market in Middle East and North Africa, till 2035 (USD Million)

Table 22.70 Proteomics Market in Israel, till 2035 (USD Million)

Table 22.71 Proteomics Market in Rest of Middle East and North Africa, till 2035 (USD Million)

Table 22.72 Proteomics Market in Rest of the World, till 2035 (USD Million)

Table 22.73 Proteomics Market in South Africa, till 2035 (USD Million)

Table 22.74 Proteomics Market in Other Countries, till 2035 (USD Million)

Table 22.75 Key Proteomics Solution Providers: Distribution by Year of Establishment

Table 22.76 Key Proteomics Solution Providers: Distribution by Company Size

Table 22.77 Key Proteomics Solution Providers: Distribution by Location of Headquarters (Region)

Table 22.78 Key Proteomics Solution Providers: Distribution by Location of Headquarters (Country)

Table 22.79 Key Proteomics Solution Providers: Distribution by Type of Offering

Table 22.80 Key Proteomics Solution Providers: Distribution by Type of Instrument / Technology

Table 22.81 Key Proteomics Solution Providers: Distribution by Type of Solution Offered

Table 22.82 Key Proteomics Solution Providers: Distribution by Application Area

Table 22.83 Agilent Technologies: Annual Revenues, FY 2021-FY 2023 (USD Billion)

Table 22.84 Bio - Rad Laboratories: Annual Revenues, FY 2021-FY 2023 (USD Billion)

Table 22.85 Bruker: Annual Revenues, FY 2021-FY 2023 (USD Billion)

Table 22.86 PerkinElmer: Annual Revenues, FY 2021-FY 2023 (USD Billion)

Table 22.87 Seer: Annual Revenues, FY 2021-FY 2023 (USD Million)

Table 22.88 Thermo Fisher Scientific: Annual Revenues, FY 2021-FY 2023 (USD Billion)

Table 22.89 Merck: Annual Revenues, FY 2021-FY 2023 (EUR Billion)

Table 22.90 Olink: Annual Revenues, FY 2021-FY 2023 (USD Million)

Table 22.91 Proteomics International: Annual Revenues, FY 2021-FY 2023 (USD Million)

+ List of Companies and Organizations

Please reach out to our team for more details.

Proteomics Market

Market Size

Market Report: Key Takeaways

Market Size & Trends

Key Market Statistics

Market Overview

Recent Developments

Market Trends

Market Share by Type of Offering

Market Share by Type of Proteomics Services

Market Share by Type of Instrument / Technology

Market Share by Type of Kit and Reagent

Market Share by Application Area

Market Share by End User

Market Share by Geography

Market Insights

Competitive Landscape of Proteomics Solution Providers

Global Proteomics Market Size Analysis: Spectrometry to Drive Market Growth

Leading Proteomics Solution Providers in the Industry

Market Segmentation Insights

Key Report Attributes

Table of Contents

The Future of Autonomous Deliveries: Integrating Drones and Self-Driving Vehicles

Radiopharmaceutical Manufacturing: A Multi-Disciplinary Endeavour for Medical Imaging and Interventional Treatment

Proteomics Market

Market Size

Market Report: Key Takeaways

Market Size & Trends

Key Market Statistics

Market Overview

Recent Developments

Market Trends

Market Share Insights

Market Share by Type of Offering

Market Share by Type of Proteomics Services

Market Share by Type of Instrument / Technology

Market Share by Type of Kit and Reagent

Market Share by Application Area

Market Share by End User

Market Share by Geography

Market Insights

Competitive Landscape of Proteomics Solution Providers

Global Proteomics Market Size Analysis: Spectrometry to Drive Market Growth

Leading Proteomics Solution Providers in the Industry

Market Segmentation Insights

Key Report Attributes

Table of Contents

The Future of Autonomous Deliveries: Integrating Drones and Self-Driving Vehicles

Radiopharmaceutical Manufacturing: A Multi-Disciplinary Endeavour for Medical Imaging and Interventional Treatment